These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2004-003847-37 An Open label uncontrolled study of the safety and efficacy of chronic intravenous Remodulin in patients with pulmonary Arterial Hypertension bad-data
Completed, but no date 2005-005011-25 Open study of BF 2.649 in association with a mood stabilizer in depressed bipolar patients bad-data
Ongoing 2005-005012-25 "Etude en simple aveugle évaluant l'efficacité et la tolérance du BF 2.649 dans le trouble de l'attention/hyperactivité de l'adulte" not-yet-due
Ongoing 2007-003512-57 Randomized, dose-finding study of BF 2.649 5, 10, 20 and 40 mg/d in comparison to placebo in Excessive Daytime Sleepiness in Parkinson’s Disease patients (PD) not-yet-due
Listed as ongoing, but also has a completion date 2008-007845-29 Essai multicentrique prospectif randomisé en double aveugle et en groupes parallèles, destiné à évaluer les effets de doses ascendantes de BF2.649 et de BF2.649 combiné à du modafinil dans le traiteme... 2010-07-03 bad-data
Listed as ongoing, but also has a completion date 2008-007866-46 Essai multicentrique prospectif randomisé en double aveugle contre placebo et en groupes parallèles, destiné à évaluer les effets du BF2.649 dans le traitement de la somnolence diurne excessive associ... 2010-07-07 bad-data
Ongoing 2009-013885-14 A randomized, multicenter 12-Week double-blind placebo-controlled study to assess the efficacy and safety of BF2.649 in Excessive Daytime Sleepiness in Parkinson’s disease followed by a 38-Week open-l... not-yet-due
Not reported 2009-013886-24 A Randomized, Multicenter, 12-Week, Double-blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson Disease, followed by a 9-mon... 2012-08-10 due-trials
Listed as ongoing, but also has a completion date 2009-017248-14 BF2.649 en pacientes con síndrome de apnea obstructiva del sueño (SAOS) tratados con presión positiva continua nasal de las vías respiratorias (nCPAP) que todavía refieren somnolencia diurna excesiva ... 2014-03-22 bad-data
Listed as ongoing, but also has a completion date 2009-017251-94 Efficacy and safety of BF2.649 in the treatment of Excessive Daytime Sleepiness in patients with Obstructive Sleep Apnoea syndrome (OSA), refusing the nasal continuous positive airway pressure (nCPAP)... 2014-05-14 bad-data
Ongoing 2010-019413-25 Minimum effective dose-finding study of BF2.649, in patients with moderate to severe Obstructive Sleep Apnea, experiencing Excessive Daytime Sleepiness (EDS) despite regular use of nCPAP, and patients... not-yet-due
Listed as ongoing, but also has a completion date 2010-019687-36 ENSAYO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y COMPARADOR, DE GRUPOS PARALELOS, PARA VALORAR LA EFICACIA DE BF2.649 EN EL TRATAMIENTO DE LA SOMNOLENCIA DIURNA EXCESIVA EN NA... 2012-07-24 bad-data
Ongoing 2010-023804-28 An open-label naturalistic pragmatic study to assess the long term safety of BF2.649 (Pitolisant) in the treatment of Excessive Daytime Sleepiness (EDS) in narcolepsy (12 months follow-up). not-yet-due
Reported results 2011-000084-27 DOUBLE BLIND RANDOMIZED STUDY TO ASSESS THE EFFICACY OF BF2.649 COMPARED TO PLACEBO IN ADD-ON TO SODIUM OXYBATE IN THE TREATMENT OF NARCOLEPTIC PATIENTS WITH RESIDUAL EXCESSIVE DAYTIME SLEEPINESS (EDS... 2014-08-12 due-trials
Not reported 2012-002731-28 Randomized placebo controlled trial assessing the efficacy and safety of BP1.4979 in smoking cessation 2014-10-09 due-trials
Listed as ongoing, but also has a completion date 2012-003076-39 A randomized, double blind study comparing BF2.649 (Pitolisant) to placebo in two parallel groups on the weekly frequency of cataplexy attacks and Excessive Daytime Sleepiness in narcoleptic patients ... 2015-01-28 bad-data
Other 2013-001506-29 DOUBLE BLIND, MULTICENTRE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE SAFETY AND EFFICACY OF PITOLISANT IN CHILDREN FROM 6 TO LESS THAN 18 YEARS WITH NARCOLEPSY WITH/WITHOUT CATAPLEXY, FOLLOWED ... not-yet-due